從作用環(huán)節(jié)角度探討《金匱》“短氣,有微飲”同病異治的內(nèi)涵
[Abstract]:This paper is discussed from three aspects: literature review, theoretical research, experimental research. Operation Gan Tang and Shenqi Pill are used in the treatment of heart disease. In clinical application, the effect of Luli Gump soup or kidney qi Pill on chronic heart failure, hypertension and other diseases is studied. In the experimental study, the mechanism of the effect of two parties on the onset of heart disease is mainly discussed from the angle of RAAS system and inflammatory factors. Tang and Shenqi pills have rich clinical practice and a solid foundation of experimental research in the prevention and treatment of heart disease. All of them can improve the "short gas, micro drink", but there are still shortcomings in the study of the connotation of "synopsis of the same disease" in the golden chamber. The interpretation of the original text and the results of the study on "disease and hetero treatment" in recent years have found that the connotation of "common disease and hetero treatment" based on the "common disease and hetero treatment" is not comprehensive, and the "same disease and the same syndrome differentiation" may exist, but the empirical study of "common disease and the same syndrome differentiation" is not perfect. The experiment selected the representative model of "short gas, micro drink" in the experiment. In this paper, the model of heart failure was selected as the representative model of "short gas and micro drink". The empirical study was carried out in two parts: the first part was based on the effect of Luli Gump Decoction and kidney qi pill based on chronic heart failure rat model. Objective: To observe whether the intervention effect of Ling Gui Shu Gan Decoction and Shenqi Pill on chronic heart failure model rats is different. Methods: 30 healthy SD rats were taken and the rat model of chronic heart failure was established by coarctation of abdominal aorta. After 10 sham operations, the model rats were divided into 1 model group, and (2) Luli Gump Decoction group; (3) kidney. Qi pill group, and began to give traditional Chinese medicine gavage for 4 weeks, the model group and sham operation group were gavage with pure water. After.4 weeks, the lung function and arterial blood gas of each group were detected. Results: the results of lung function and blood gas analysis were compared with the sham operation group, the model group was FVC, FEV1/FVC decreased (P0.05), arterial blood pH, Pa0 2, SO2 decreased (P0.05) and PaCO2 increased (P0.05). It suggested that the model rats had cardiac dysfunction. Compared with the model group, the lung function and arterial blood gas of the kidney qi pill group were improved (P0.05). The difference of lung function and blood gas between the Gump Decoction group and the kidney qi pill group was not significant (P0.05). Shenqi Pill can improve the heart function of chronic heart failure rats, that is, it can improve the "short gas". And the difference of the effect of the two parties is not significant. Conclusion: Luli Gump Decoction and kidney qi pill can improve the heart function of the rat model of chronic heart failure, and the difference of the effect of the two parties is not significant, that is, the interpretation of "the same disease and the disease and the treatment" is possible. The second part is based on the slow effect. The purpose of the study is to study the mechanism of Luli Gump Decoction and Shenqi Pill to improve the chronic heart failure from the point of action. Luli Gump soup group; (3) model group: (4) sham operation group. Detection of lung function, arterial blood gas, hemodynamic parameters, myocardial pathology (HE staining) observation, urine volume of rat 24h rats were collected by metabolic cage, Na+, K+, Cl- concentration in urine of rats were detected by automatic analyzer; AQP2 concentration in urine was detected by ELISA method; ELISA method was used to detect PRA and Ang in serum, Ang. II, ALD concentration, concentration of inflammatory factors (IL-6, IL-10, IL-18, IL-1 beta), CRP concentration. Results: compared with the sham group, the results of lung function and blood gas analysis were compared with the sham operation group. The rats in the model group decreased (P0.05), pH, Pa02, Sa02 all decreased. It suggested that the model rats have cardiac dysfunction, that is, "short breath". The model group was compared, the lung function and arterial blood gas of the rats in the kidney qi pill group were improved (P0.05). The results suggested that the two parties could improve the heart function of the rats with chronic heart failure. The lung function and arterial blood gas of the rats in the Gump Decoction group and the kidney qi pill group were compared (P0.05). The difference between the two parties was not significant, and the "short" could improve the "short". The urine volume, urine Na+, K+, Cl- concentration, AQP2 concentration test results compared with the sham operation group, the urine volume decreased (P0.05), the urine Na+, Cl- concentration decreased (P0.05), the K+ concentration increased (P0.05), the urine AQP2 concentration increased (P0.05), suggesting that the model rats had water retention. Compared with the model group, Luli Gump soup was compared with the model group. The urine volume of rats in Shenqi Pill group increased (P0.05), Luli Gump Decoction group, kidney qi pill group Na+, Cl- concentration significantly increased (P0.05), K+ concentration decreased significantly (P0.05), AQP2 concentration in urine of kidney qi pill group decreased (P0.05), suggesting that the above two parties could improve the retention of water in rat model rats and kidney qi pill group and kidney qi pill group rats urine. The difference was not statistically significant (P0.05), suggesting that the difference of water retention in the model rats was not significant. The results of serum PRA, Ang II and ALD concentration in serum were compared with the sham operation group: the arterial blood of rats in the model group was PRA, Ang II, and ALD content increased (P0.05), suggesting the activation of RAAS system in the rat model of heart failure. Compared with the model group: the rats of Luli Gump Decoction group, the rats of kidney qi pill group rats PRA, ALD decreased (P0.05), Ang II decreased not significantly (P0.05), suggesting that the two parties can reduce PRA and ALD generation and inhibit RAAS system activation. Compared with the Luli Gump Decoction group, the kidney qi pill group rats ALD significantly decreased (P0.05). Suggesting that two parties can inhibit ALD raw. It could inhibit the activation of RAAS system, but the effect of kidney qi pill was significant. The results of serum inflammatory factors (IL-6, IL-10, IL-18, IL-1 beta) and CRP concentration were compared with the sham operation group: the serum IL-6, IL-18, IL-10, TNF- a, IL-1 beta and CRP all increased in the model group, suggesting that the inflammatory factors in the model rats were activated. The concentration of IL-6, IL-18, IL-10 and IL-1 beta in the serum of Gump Decoction group decreased (P0.05), and the concentration of IL-6, IL-10 and IL-1 beta in the serum of kidney qi pill group decreased (P0.05). The concentration of IL-10 and IL-18 increased (P0.05) in the kidney qi pill group. To inhibit the inflammatory reaction. Myocardial histopathology was observed in the sham operation group: the size of the myocardium, the shape of the myocardium was normal, the myocardial fibers were arranged regularly. The transverse diameter of the cardiac myocytes in the model group was enlarged, the myocardial fibers were thickened, the rupture, the nucleus increased, the morphology was irregular, the nucleolus concentration, and the interstitial hyperplasia were changed by HE staining in the Gump Decoction group and the kidney qi pill group. Compared with the model group, the pathological changes of the two groups were not significant. Compared with the sham group, the heart rate (HR) and the maximum increase rate of left indoor pressure (+dp/dtmax) decreased significantly (P0.05), and the left ventricular diastolic pressure (LVEDP) was significantly increased (P0.05) in the model group. The heart rate (HR) of Gan Tang Group (P0.05), left ventricular end diastolic pressure (LVEDP) decreased significantly (P0.05), kidney qi pill group heart rate (HR), left ventricular systolic pressure (LVSP), and the maximum rise rate of left ventricular pressure (+dp/ dtmax) increased significantly (P0.05). It suggested that Luli Gump soup and kidney qi pills could improve the blood of model rats. Flow mechanics. Luli Gump Decoction group and kidney qi pill group (P0.05). Suggesting that Ling Gui Shu Gan Decoction and Shenqi Pill have no significant difference in effect of improving the model rats' diastolic dysfunction. Conclusion: Luli Gan Tanghe kidney qi pill can improve the heart function of the model rats, and the difference of the intervention effect of the two parties is not significant. Heteronomy "is possible". The connotation of its existence may be the different links between the two parties acting on chronic heart failure.
【學(xué)位授予單位】:北京中醫(yī)藥大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2017
【分類號】:R222.3
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 黃仔萍;;苓桂術(shù)甘湯加味在調(diào)治正常高值血壓中的應(yīng)用[J];中國中醫(yī)藥科技;2016年02期
2 劉旭東;付堅(jiān);封木忠;章正華;;金匱腎氣丸聯(lián)合硝苯地平控釋片治療老年脾腎陽虛型高血壓的效果觀察[J];中國中藥雜志;2015年24期
3 茹立良;王華斌;范坤;;常振森主任醫(yī)師用金匱腎氣丸湯方經(jīng)驗(yàn)總結(jié)[J];世界中醫(yī)藥;2015年11期
4 姚優(yōu)修;孫興國;李軍;譚曉越;張宏亮;王古巖;葛萬剛;劉方;李浩;慈政;胡盛壽;;心衰患者動脈血?dú)獠ɡ耸阶兓捌浞冉档偷某醪綄?shí)驗(yàn)證據(jù)[J];中國應(yīng)用生理學(xué)雜志;2015年04期
5 徐文聃;王欣;王琛;楊元宵;李守業(yè);李昌煜;;從下丘腦-垂體-腎上腺皮質(zhì)軸探討附子肉桂在腎氣丸中補(bǔ)腎陽的作用[J];浙江中醫(yī)藥大學(xué)學(xué)報(bào);2014年07期
6 孫興國;譚曉越;張健;黃潔;關(guān)越;楊江萍;楊晶晶;馬莉;時(shí)曉蕾;;慢性心衰患者肺功能檢查的臨床意義及其特征性改變的初步分析[J];中國實(shí)用內(nèi)科雜志;2013年S1期
7 張雨田;;苓桂術(shù)甘湯治療慢性心力衰竭的臨床觀察[J];中西醫(yī)結(jié)合心腦血管病雜志;2013年06期
8 龔明玉;杜超;許倩;李素婷;;苓桂術(shù)甘湯對大鼠心肌缺血再灌注損傷心肌細(xì)胞凋亡的影響[J];中國實(shí)驗(yàn)方劑學(xué)雜志;2012年23期
9 王靚;侯曉燕;保永亮;黃金玲;方海雁;施慧;程曉煜;;苓桂術(shù)甘湯對急性心肌梗死心室重構(gòu)模型大鼠TNF-α、IL-6和ET-1的影響[J];山西中醫(yī)學(xué)院學(xué)報(bào);2012年04期
10 廖月玲;劉艷;顧燕頻;黃瑋;章忱;袁寶萍;呂嶸;衛(wèi)洪昌;;金匱腎氣丸對異丙腎上腺素致大鼠心室重構(gòu)不同階段的影響[J];中國中醫(yī)藥信息雜志;2012年06期
,本文編號:2128192
本文鏈接:http://sikaile.net/zhongyixuelunwen/2128192.html